Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-07-22
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546183, A61K 31435, C07D47104
Patent
active
056504136
ABSTRACT:
The invention relates to novel mannosidase inhibitors, processes for their preparation and their use as therapeutic agents. The invention also relates to pharmaceutical compositions containing the compounds and their use as therapeutics.
REFERENCES:
patent: 3274202 (1966-09-01), Mohrbacher
patent: 4857315 (1989-08-01), Dennis
Villiani et al., J. Org. Chem. 6, pp. 142-144 (1962).
Clemo et al., J. Chem. Soc., pp. 1518-1523 (1937).
Hibbert et al., J. Het. Chem. 7, 857-61 (1970).
Fujiwara et al., Shitsury Bunseki 40(3) pp. 159-163 (1992); Chem. Abst. vol. 117, 211862e (1992).
Boegesoe et al., J. Med. Chem. 30(1), pp. 142-150 (1987); Chem. Abst. vol. 106, 84369v (1987).
Holden et al, J. Chem. Soc. pp. 2545-2546 (1963).
Leonard et al., J. Org. Chem. 22, pp. 1445-1451 (1957); Chem. Abst., vol. 52, 8134c (1958).
Colegate et al., Aust. J. Chem. 32:2257-2264, 1979.
Molyneux R.J. and James L.F., Science 215:190-191, 1981.
Schneider et al., Tetrahedron 39:29-32, 1983.
Tulsiani et al., J. Biol. Chem. 257:7936-7939, 1982.
Fernandes et al., Cancer Res. 51:718-723, 1991.
Dennis J.W., Cell Surface Carbo. and Cell Devel., ed. Fukuda, pp. 161-194. CRC Press, Boca Raton, 1991.
Dennis et al., Science 236:582-585, 1987.
VanderElst I. and Dennis J.W., Exp. Cell Res. 192:612-621, 1991.
Dennis J.W., Cancer Res. 46:5131-5136, 1986.
Humphries et al., Proc. Natl. Acad. Sci. U.S.A. 83:1752-1756, 1986.
Yagel et al., Int. J. Cancer 44:685-690, 1989.
Seftor et al., Melanoma Res. 1:43-54, 1991.
Dennis et al., J. Natl. Cancer Inst. 81:1028-1033, 1989.
Dennis et al., Cancer Res. 50:1867-1872, 1990.
Humphries M.J. and Olden K., Pharmacol Ther. 44:85-105, 1989.
Olden et al., Pharmacol Ther. 50:285-290, 1991.
Humphries et al, Cancer Res. 48:1410-1415, 1988.
Yagita M. and Saksela E., Scand. J. Immunol. 31:275-282, 1990.
White et al., Biochem. Biophys. Res. Commun. 150:615-625, 1988.
Bowlin et al., Cancer Res. 49:4109-4113, 1989.
White et al., Cancer Commun. 3:83-91, 1991.
Oredipe et al., J. Natl. Cancer Institue 83:1149-1156, 1991.
Dennis J.W. et al., Biochemical Pharmacology 46:1459-1466, 1993.
Hashimoto et al., Chemical Abstracts, Abstract No. 138253y, 106:673, 1987.
Heidt et al., Tetrahedron Letters, 31:5441-5444, 1990.
Miyano et al., Chemical Abstracts, Abstract No. 179148c 98:637, 1983.
Aoyama et al., J. of Org. Chem., 57:3037-3041, 1992.
Reinecke et al., J. of Org. Chem., 29:1736-1747, 1964.
Chastanet et al., J. of Org. Chem., 50:2910-14, 1985.
Reinecke and Kray, J. of Org. Chem., 30:671-76, 1965.
Leonard et al., J. of Org. Chem., 22:1445-51, 1957.
Wilson et al., J. of Org. Chem., 44:330-336, 1979.
Smith et al., Chemical Abstracts, Abstract No. 51007f, 104:537, 1986.
Biniecki et al., Chemical Abstracts, Abstract No. 138204h, 106:668, 1987.
Yoon et al., Chemical Abstracts, Abstract No. 38827r, 97:563, 1982.
Winterfeld et al., Chemical Abstrcts, Abstract No. 3456s, 74:281, 1971.
Hibbett et al., J. of Heter. Chem., 7:857-61, 1970.
Biniecki et al., Chemical Abstracts, Abstract No. 90743a, 101:624, 1984.
Winkler et al., J. of Med. Chem., 32:2084-2089, 1989.
Carver Jeremy
Shah Rajan
Dentz Bernard
Glycodesign Inc.
LandOfFree
Derivatives of swainsonine, processes for their preparation and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of swainsonine, processes for their preparation and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of swainsonine, processes for their preparation and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560123